about
Structure-activity relationship study of tetrapeptide inhibitors of the Vascular Endothelial Growth Factor A binding to Neuropilin-1.SCRAMBLE'N'GAMBLE: a tool for fast and facile generation of random data for statistical evaluation of QSAR models.Chirality measures of α-amino acids.Conformational latitude - activity relationship of KPPR tetrapeptide analogues toward their ability to inhibit binding of vascular endothelial growth factor 165 to neuropilin-1.Structural Insights into σ₁ Receptor Interactions with Opioid Ligands by Molecular Dynamics Simulations.Hydrazone Linker as a Useful Tool for Preparing Chimeric Peptide/Nonpeptide Bifunctional Compounds.Structure-activity relationship study of a small cyclic peptide H-c[Lys-Pro-Glu]-Arg-OH: a potent inhibitor of Vascular Endothelial Growth Factor interaction with Neuropilin-1.Structural studies on radiopharmaceutical DOTA-minigastrin analogue (CP04) complexes and their interaction with CCK2 receptor.On the Substituent Effect in the First Excited Singlet State of Monosubstituted Benzenes.Fentanyl Family at the Mu-Opioid Receptor: Uniform Assessment of Binding and Computational AnalysisTriazolopeptides Inhibiting the Interaction between Neuropilin-1 and Vascular Endothelial Growth Factor-165.Design, synthesis and in vitro biological evaluation of a small cyclic peptide as inhibitor of vascular endothelial growth factor binding to neuropilin-1The analgesic hybrid of dermorphin/substance P and analog of enkephalin improve wound healing in streptozotocin-induced diabetic ratsBranched pentapeptides as potent inhibitors of the vascular endothelial growth factor 165 binding to Neuropilin-1: Design, synthesis and biological activityMolecular dynamics of fentanyl bound to μ-opioid receptorAffinity of fentanyl and its derivatives for the σ1-receptorβ2-Homo-Amino Acid Scan of µ-Selective Opioid Tetrapeptide TAPP
P50
Q38669500-39AAC1A4-9F5B-49D0-9EE2-E06B2BC8AE51Q47101590-0B6DF08F-BA96-448D-AD05-20D2A75CFEA8Q47762336-5619C3BA-2385-4C4A-9BAD-65A03A8BF47CQ48201168-806318F6-FC83-4DB2-8221-23415C80FF3CQ49803862-BCCA2A3B-E1BC-4B5C-8D14-64C3829C0710Q51037057-ACD78359-4BC5-4DAE-BCF6-A3792CA3C3CFQ51302575-95C44BD7-165E-495E-90F7-F882E505C663Q52319422-0F78CFEC-508C-4DAD-B248-6A5AAD88AF84Q52561156-E4230394-1FEC-4B6F-850C-5D5AAE271C15Q64259341-9E44161A-A77D-4D7B-B7D3-B0D40E2515C4Q64988358-369CE24A-6A21-450A-AED6-01DCFC4ED74EQ89363648-EB70CB02-2992-4F6B-8386-35FFE0B87B4FQ91020026-0D6CA5B4-236B-4073-94A2-92AAC5EE9939Q91628313-BEA1EFA6-5E13-4539-BA6F-517D8DF4D8E3Q91753816-B958F3D5-D687-4172-9521-CA67A8E9A091Q92485821-677B2307-26D0-4A75-AA9B-3328FB0A193FQ95930216-C3228DAD-FED5-48D6-B10F-163AC76591FB
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Piotr F J Lipiński
@en
Piotr F J Lipiński
@nl
type
label
Piotr F J Lipiński
@en
Piotr F J Lipiński
@nl
prefLabel
Piotr F J Lipiński
@en
Piotr F J Lipiński
@nl
P31
P496
0000-0002-8364-7955